PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
Bate, J Baker, S Breuer, J Chisholm, J Gray, J Hambleton, S Houlton, A Jit, M Lowis, S Makin, Guy W J
Bate, J
Baker, S
Breuer, J
Chisholm, J
Gray, J
Hambleton, S
Houlton, A
Jit, M
Lowis, S
Makin, Guy W J
Citations
Altmetric:
Abstract
To determine the likely rate of patient randomisation and to facilitate sample size calculation for a full-scale phase III trial of varicella zoster immunoglobulin (VZIG) and aciclovir as postexposure prophylaxis against chickenpox in children with cancer.
Description
Date
2018-05-05
Publisher
Collections
Keywords
Type
Article
Citation
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. 2018, Arch Dis Child